Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)
Apr 18
Have your own idea? Try our Stock Screener
Indian (NIFTY) Biotech Industry Analysis
UpdatedApr 25, 2025
DataAggregated Company Financials
Companies9
- 7D-0.6%
- 3M-12.8%
- 1Y17.8%
- YTDn/a
The Biotech is pretty flat in the last 7 days, but Hester Biosciences has stood out, gaining 10%. The past year has been better, since the industry has gained 18% in that time. Looking forward, earnings are forecast to grow by 25% annually.
Industry Valuation and Performance
Has the Indian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 25 Apr 2025 | ₹447.6b | ₹158.8b | ₹8.5b | 53.2x | 52.4x | 2.8x |
| Sun, 23 Mar 2025 | ₹457.2b | ₹158.9b | ₹8.4b | 51.2x | 54.7x | 2.9x |
| Tue, 18 Feb 2025 | ₹457.2b | ₹158.9b | ₹8.4b | 51.7x | 54.7x | 2.9x |
| Thu, 16 Jan 2025 | ₹509.2b | ₹159.6b | ₹14.5b | 58.1x | 35x | 3.2x |
| Sat, 14 Dec 2024 | ₹480.3b | ₹159.6b | ₹14.5b | 39.3x | 33x | 3x |
| Mon, 11 Nov 2024 | ₹438.3b | ₹159.0b | ₹14.3b | 40.9x | 30.6x | 2.8x |
| Wed, 09 Oct 2024 | ₹455.6b | ₹157.7b | ₹15.7b | 31.2x | 29x | 2.9x |
| Fri, 06 Sep 2024 | ₹503.1b | ₹157.7b | ₹15.7b | 34.5x | 32x | 3.2x |
| Sun, 04 Aug 2024 | ₹469.4b | ₹157.3b | ₹10.4b | 41.7x | 45.3x | 3x |
| Tue, 02 Jul 2024 | ₹463.2b | ₹157.4b | ₹10.4b | 43.7x | 44.5x | 2.9x |
| Thu, 30 May 2024 | ₹417.0b | ₹157.3b | ₹10.3b | 45.1x | 40.6x | 2.7x |
| Sat, 27 Apr 2024 | ₹396.7b | ₹155.4b | ₹12.0b | 37.5x | 33x | 2.6x |
| Mon, 25 Mar 2024 | ₹328.2b | ₹155.4b | ₹12.0b | 33.1x | 27.3x | 2.1x |
| Wed, 21 Feb 2024 | ₹366.5b | ₹155.4b | ₹12.0b | 39.9x | 30.5x | 2.4x |
| Fri, 19 Jan 2024 | ₹366.6b | ₹145.0b | ₹5.3b | 59x | 69.8x | 2.5x |
| Sun, 17 Dec 2023 | ₹331.2b | ₹145.0b | ₹5.3b | 54.4x | 63x | 2.3x |
| Tue, 14 Nov 2023 | ₹301.7b | ₹145.0b | ₹5.2b | 53.2x | 57.6x | 2.1x |
| Thu, 12 Oct 2023 | ₹338.5b | ₹133.8b | ₹4.8b | 32.3x | 70.8x | 2.5x |
| Sat, 09 Sep 2023 | ₹347.4b | ₹133.8b | ₹4.8b | 30.2x | 72.7x | 2.6x |
| Mon, 07 Aug 2023 | ₹331.3b | ₹120.4b | ₹4.5b | 41.5x | 73.3x | 2.8x |
| Wed, 05 Jul 2023 | ₹341.4b | ₹120.4b | ₹4.5b | 41.9x | 75.7x | 2.8x |
| Fri, 02 Jun 2023 | ₹319.3b | ₹120.8b | ₹4.5b | 40.5x | 71.2x | 2.6x |
| Sun, 30 Apr 2023 | ₹309.0b | ₹106.6b | ₹16.4b | 17.3x | 18.9x | 2.9x |
| Tue, 28 Mar 2023 | ₹275.5b | ₹106.6b | ₹16.4b | 23x | 16.8x | 2.6x |
| Thu, 23 Feb 2023 | ₹296.1b | ₹106.3b | ₹16.3b | 35x | 18.2x | 2.8x |
| Sat, 21 Jan 2023 | ₹326.2b | ₹99.2b | ₹18.0b | 31.1x | 18.2x | 3.3x |
| Mon, 19 Dec 2022 | ₹351.1b | ₹99.2b | ₹18.0b | 33.8x | 19.6x | 3.5x |
| Wed, 16 Nov 2022 | ₹373.2b | ₹95.7b | ₹18.2b | 31.6x | 20.5x | 3.9x |
| Fri, 14 Oct 2022 | ₹349.2b | ₹95.5b | ₹18.1b | 30.1x | 19.3x | 3.7x |
| Sun, 11 Sep 2022 | ₹398.0b | ₹95.5b | ₹18.1b | 34.1x | 22x | 4.2x |
| Tue, 09 Aug 2022 | ₹415.0b | ₹95.8b | ₹18.3b | 33.8x | 22.7x | 4.3x |
| Thu, 07 Jul 2022 | ₹418.8b | ₹92.1b | ₹17.7b | 31.1x | 23.7x | 4.5x |
| Sat, 04 Jun 2022 | ₹420.9b | ₹92.0b | ₹17.5b | 31.7x | 24x | 4.6x |
| Mon, 02 May 2022 | ₹475.9b | ₹87.6b | ₹6.9b | 60.8x | 68.7x | 5.4x |
Price to Earnings Ratio
68.7x
Current Industry PE
- Investors are optimistic on the Indian Biotechnology industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 52.4x which is higher than its 3-year average PE of 39.7x.
- The industry is trading close to its 3-year average PS ratio of 3.1x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have grown 7.2% per year over the last three years.
- Revenues for these companies have grown 22% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Indian Biotech compare with similar industries?
| IN Market | 2.30% | |
| Healthcare | 2.71% | |
| Biotech | -0.63% | |
| Biotech | -0.63% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 524669 Hester Biosciences | ₹1.95k | 10.3% +₹1.5b | 17.4% | PE53.2x | |
| PANACEABIO Panacea Biotec | ₹538.35 | 2.9% +₹943.3m | 267.5% | PS5.9x | |
| NIRMAN Nirman Agri Genetics | ₹280.45 | 6.4% +₹100.7m | 27.1% | PE7.8x | |
| 524663 Bharat Immunologicals & Biologicals | ₹24.34 | 3.6% +₹36.7m | -26.0% | n/a | |
| 514336 Genesis IBRC India | ₹19.25 | 5.0% +₹11.8m | n/a | PS6.8x |